Articles

How the tech giants co-opted the world of open source

On 28 October 2018, it was announced that IBM will buy open source software company, Red Hat, for $34 billion. This is a landmark deal, as the biggest IBM has made in its more-than-a-hundred year history, and the third largest deal ever for a US tech company. It also moves IBM...

Read more

Demonstrating how software can qualify for a patent through virtual reality

Along with artificial intelligence and blockchain, virtual reality (VR) and augmented reality (AR) have long been billed as technologies in development today that have the potential to transform our future. There were some false starts in AR/VR – for example the promise of Google Glass is still yet to be...

Read more

Success of AI-driven healthcare depends on robust IP strategies

Artificial Intelligence in healthcare is undoubtedly having a moment. It is already transforming fields such as medical imaging where AI revolutionises image analysis, expanding its reach and improving overall quality. With the UK Government planning an AI revolution, healthcare AI start-ups stand to benefit, but only if they place Intellectual...

Read more

AI-generated in silico data in patent applications

The impact of AI-generated in silico data on pharma patent applications In silico data generated using AI platforms can identify existing medication candidates and match them with diseases and conditions that do not yet have a cure much quicker and more reliably than a human will ever be able to do. However, it...

Read more

Five key changes in EPO examiner guidelines relating to computer implemented inventions

The EPO released its latest (2018) edition of the Guidelines for Examination on 1 October 2018. This release includes a number of updates in the Computer Implemented Invention (CII) field. We think there are five key points of which applicants should be aware. Distributed computing environments The EPO defines a...

Read more